vs
科迪华（CTVA）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是RENAISSANCERE HOLDINGS LTD的1.8倍（$3.9B vs $2.2B），RENAISSANCERE HOLDINGS LTD净利率更高（23.5% vs -14.1%，领先37.6%），科迪华同比增速更快（-1.7% vs -36.8%），过去两年科迪华的营收复合增速更高（-6.7% vs -11.9%）
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
CTVA vs RNR — 直观对比
营收规模更大
CTVA
是对方的1.8倍
$2.2B
营收增速更快
CTVA
高出35.0%
-36.8%
净利率更高
RNR
高出37.6%
-14.1%
两年增速更快
CTVA
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.9B | $2.2B |
| 净利润 | $-552.0M | $515.8M |
| 毛利率 | 42.4% | — |
| 营业利润率 | -13.6% | — |
| 净利率 | -14.1% | 23.5% |
| 营收同比 | -1.7% | -36.8% |
| 净利润同比 | -1246.3% | 72.6% |
| 每股收益（稀释后） | $-0.80 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTVARNR
| Q1 26 | — | $2.2B | ||
| Q4 25 | $3.9B | $3.0B | ||
| Q3 25 | $2.6B | $3.2B | ||
| Q2 25 | $6.5B | $3.2B | ||
| Q1 25 | $4.4B | $3.5B | ||
| Q4 24 | $4.0B | $2.3B | ||
| Q3 24 | $2.3B | $4.0B | ||
| Q2 24 | $6.1B | $2.8B |
净利润CTVARNR
| Q1 26 | — | $515.8M | ||
| Q4 25 | $-552.0M | $760.5M | ||
| Q3 25 | $-320.0M | $916.5M | ||
| Q2 25 | $1.3B | $835.4M | ||
| Q1 25 | $652.0M | $170.0M | ||
| Q4 24 | $-41.0M | $-189.7M | ||
| Q3 24 | $-524.0M | $1.2B | ||
| Q2 24 | $1.1B | $503.9M |
毛利率CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | 42.4% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 54.6% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 52.3% | — |
营业利润率CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | -13.6% | 42.5% | ||
| Q3 25 | -14.1% | 46.3% | ||
| Q2 25 | 27.9% | 41.8% | ||
| Q1 25 | 17.7% | -2.0% | ||
| Q4 24 | 2.2% | -3.6% | ||
| Q3 24 | -27.2% | 43.7% | ||
| Q2 24 | 21.9% | 25.0% |
净利率CTVARNR
| Q1 26 | — | 23.5% | ||
| Q4 25 | -14.1% | 25.6% | ||
| Q3 25 | -12.2% | 28.7% | ||
| Q2 25 | 20.4% | 26.1% | ||
| Q1 25 | 14.8% | 4.9% | ||
| Q4 24 | -1.0% | -8.3% | ||
| Q3 24 | -22.5% | 29.8% | ||
| Q2 24 | 17.2% | 17.8% |
每股收益（稀释后）CTVARNR
| Q1 26 | — | $6.57 | ||
| Q4 25 | $-0.80 | $16.16 | ||
| Q3 25 | $-0.47 | $19.40 | ||
| Q2 25 | $1.92 | $17.20 | ||
| Q1 25 | $0.95 | $3.27 | ||
| Q4 24 | $-0.05 | $-3.76 | ||
| Q3 24 | $-0.76 | $22.62 | ||
| Q2 24 | $1.51 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $1.6B |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $24.1B | $4.3B |
| 总资产 | $42.8B | $53.7B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资CTVARNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $4.5B | $1.7B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.1B | $1.4B | ||
| Q1 25 | $2.0B | $1.6B | ||
| Q4 24 | $3.2B | $1.7B | ||
| Q3 24 | $2.5B | $1.6B | ||
| Q2 24 | $2.0B | $1.6B |
总债务CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $2.3B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $2.3B | ||
| Q1 25 | $1.8B | $2.8B | ||
| Q4 24 | $2.0B | $1.9B | ||
| Q3 24 | $2.0B | $1.9B | ||
| Q2 24 | $2.5B | $2.0B |
股东权益CTVARNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $24.1B | $11.6B | ||
| Q3 25 | $25.2B | $11.5B | ||
| Q2 25 | $25.9B | $10.8B | ||
| Q1 25 | $24.3B | $10.3B | ||
| Q4 24 | $23.8B | $10.6B | ||
| Q3 24 | $24.7B | $11.2B | ||
| Q2 24 | $25.2B | $10.2B |
总资产CTVARNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $42.8B | $53.8B | ||
| Q3 25 | $42.2B | $54.5B | ||
| Q2 25 | $41.8B | $54.7B | ||
| Q1 25 | $42.1B | $53.6B | ||
| Q4 24 | $40.8B | $50.7B | ||
| Q3 24 | $41.9B | $52.8B | ||
| Q2 24 | $41.5B | $51.6B |
负债/权益比CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | 0.07× | 0.20× | ||
| Q3 25 | 0.07× | 0.19× | ||
| Q2 25 | 0.07× | 0.21× | ||
| Q1 25 | 0.07× | 0.27× | ||
| Q4 24 | 0.08× | 0.18× | ||
| Q3 24 | 0.08× | 0.17× | ||
| Q2 24 | 0.10× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4B | — |
| 自由现金流经营现金流 - 资本支出 | $4.2B | — |
| 自由现金流率自由现金流/营收 | 106.2% | — |
| 资本支出强度资本支出/营收 | 5.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.8B | — |
8季度趋势，按日历期对齐
经营现金流CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | $4.4B | $483.0M | ||
| Q3 25 | $193.0M | $1.6B | ||
| Q2 25 | $947.0M | $1.5B | ||
| Q1 25 | $-2.1B | $157.8M | ||
| Q4 24 | $4.2B | $778.9M | ||
| Q3 24 | $130.0M | $1.5B | ||
| Q2 24 | $451.0M | $1.2B |
自由现金流CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | — | ||
| Q3 25 | $36.0M | — | ||
| Q2 25 | $829.0M | — | ||
| Q1 25 | $-2.2B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $-24.0M | — | ||
| Q2 24 | $337.0M | — |
自由现金流率CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | 106.2% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | -49.9% | — | ||
| Q4 24 | 100.4% | — | ||
| Q3 24 | -1.0% | — | ||
| Q2 24 | 5.5% | — |
资本支出强度CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 1.9% | — |
现金转化率CTVARNR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | 0.72× | 1.76× | ||
| Q1 25 | -3.23× | 0.93× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | 0.43× | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
RNR
暂无分部数据
